Xcout Intel
Phaeosynt
Headquartered in Hanover, Germany, Phaeosynt is a biotechnology company founded to produce animal-free antibodies using diatoms instead of traditional methods.
Subscribe to see Phaeosynt’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Phaeosynt at a glance
Phaeosynt is a biotechnology company headquartered in Germany. Its most recent funding round, Pre-Seed, raised $1.8M in February 2025. Xcout tracks 3 named people at Phaeosynt, including Stephanie Pfeil-Coenen (CEO, Geschäftsführung, Finanzen, Vertrieb).
Phaeosynt leadership
- Stephanie Pfeil-CoenenCEO, Geschäftsführung, Finanzen, Vertrieb
- Dr. Alina EilersCOO, Geschäftsführung, Kooperationen, QM
- Stas HansCTO, Forschung, Entwicklung
Phaeosynt funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $1.8M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Phaeosynt's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Phaeosynt in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access